Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

The emergence of the novel coronavirus disease 2019 (COVID-19) pandemic has become a major public health challenge of global concern since December 2019, when the virus was recognized in Wuhan, the capital city of Hubei province in China and epicenter of the COVID-19 epidemic. Given the novelty of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamdy, Sherif M, Abdel-Naseer, Maged, Shehata, Hatem S, Hassan, Amr, Elmazny, Alaa, Shalaby, Nevin M, Abokrysha, Noha T, Kishk, Nirmeen A, Nada, Mona A F, Ahmed, Sandra M, Hegazy, Mohamed I, Mekkawy, Doaa, Mourad, Husam S, Abdelalim, Ahmed, Berger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398889/
https://www.ncbi.nlm.nih.gov/pubmed/32801722
http://dx.doi.org/10.2147/TCRM.S257714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398889/
https://www.ncbi.nlm.nih.gov/pubmed/32801722
http://dx.doi.org/10.2147/TCRM.S257714

Ejemplares similares